CrossLiner's ™ Guide Extension System is intended to allow safe, deep, coronary intubation.
CrossLiner™ was founded in 2018, by Drs. Tim Fischell and Frank Saltiel, with a goal to create next generation guide catheter extension products that would overcome many of the limitations of first generation guide catheter extension.
CrossLiner™ is now poised to seek 510 (K) clearance of the CrossLiner™ Microcatheter product.
The company plans to develop and commercialize at least three additional, novel CrossLiner™ products in the next several years.
CrossLiner™ is founded with the goal of creating novel interventional products to assist cardiologists to better care for their patients. The company is committed to innovation and integrity of its brand to promote excellent patient outcomes.
Fischell TA, Payne J, Wehde K, Saltiel FS. A next generation guide extension system for percutaneous coronary intervention. Cardiovascular Revasc. Medicine; 2020 Cardiovasc Revasc Med. 2020 Dec 28;S1553-8389(20)30809-5.